Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT00390104

Molecular Analysis of Patients With Neuromuscular Disease

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and limb-girdle muscle dystrophy (LGMD). There are still many patients diagnosed with muscular dystrophy with no causative gene implicated in their disease. Using molecular genetics to unravel basis of these neuromuscular disorders will lead to more accurate diagnosis/prognosis of these disorders which will lead to potential therapies.

Official title: Molecular Analysis of Nucleic Acids Derived From Patients With Neuromuscular Disease and Their Family Members

Key Details

Gender

All

Age Range

1 Week - 100 Years

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2002-01

Completion Date

2027-12-31

Last Updated

2023-04-24

Healthy Volunteers

No

Locations (1)

Boston Children's Hospital

Boston, Massachusetts, United States